210 related articles for article (PubMed ID: 22970170)
21. Evaluation of the therapeutic potential effect of Fas receptor gene knockdown in experimental model of non-alcoholic steatohepatitis.
Savari F; Badavi M; Rezaie A; Gharib-Naseri MK; Mard SA
Free Radic Res; 2019 May; 53(5):486-496. PubMed ID: 31010354
[No Abstract] [Full Text] [Related]
22. Interleukin-35 Gene-Modified Mesenchymal Stem Cells Protect Concanavalin A-Induced Fulminant Hepatitis by Decreasing the Interferon Gamma Level.
Wang W; Guo H; Li H; Yan Y; Wu C; Wang X; He X; Zhao N
Hum Gene Ther; 2018 Feb; 29(2):234-241. PubMed ID: 29054137
[TBL] [Abstract][Full Text] [Related]
23. Small heterodimer partner negatively regulates C-X-C motif chemokine ligand 2 in hepatocytes during liver inflammation.
Noh JR; Kim YH; Kim DK; Hwang JH; Kim KS; Choi DH; Lee SJ; Lee HG; Lee TG; Weng HL; Dooley S; Choi HS; Lee CH
Sci Rep; 2018 Oct; 8(1):15222. PubMed ID: 30323351
[TBL] [Abstract][Full Text] [Related]
24. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
[TBL] [Abstract][Full Text] [Related]
25. Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation.
Zhu L; Mahato RI
Bioconjug Chem; 2010 Nov; 21(11):2119-27. PubMed ID: 20964335
[TBL] [Abstract][Full Text] [Related]
26. Liver-specific Fas silencing prevents galactosamine/lipopolysaccharide-induced liver injury.
Kuhla A; Thrum M; Schaeper U; Fehring V; Schulze-Topphoff U; Abshagen K; Vollmar B
Apoptosis; 2015 Apr; 20(4):500-11. PubMed ID: 25601293
[TBL] [Abstract][Full Text] [Related]
27. Caspase 8 small interfering RNA prevents acute liver failure in mice.
Zender L; Hutker S; Liedtke C; Tillmann HL; Zender S; Mundt B; Waltemathe M; Gosling T; Flemming P; Malek NP; Trautwein C; Manns MP; Kuhnel F; Kubicka S
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7797-802. PubMed ID: 12810955
[TBL] [Abstract][Full Text] [Related]
28. Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice.
Xu X; Hu Y; Zhai X; Lin M; Chen Z; Tian X; Zhang F; Gao D; Ma X; Lv L; Yao J
Toxicol Appl Pharmacol; 2013 Nov; 273(1):68-76. PubMed ID: 23993977
[TBL] [Abstract][Full Text] [Related]
29. IL-33 ameliorates liver injury and inflammation in Poly I:C and Concanavalin-A induced acute hepatitis.
Khan HA; Munir T; Khan JA; Shafia Tehseen Gul AH; Ahmad MZ; Aslam MA; Umar MN; Arshad MI
Microb Pathog; 2021 Jan; 150():104716. PubMed ID: 33383149
[TBL] [Abstract][Full Text] [Related]
30. Hepatocyte-targeted psiRNA delivery mediated by galactosylated poly(ethylene glycol)-graft-polyethylenimine in vitro.
Nie C; Liu C; Chen G; Dai J; Li H; Shuai X
J Biomater Appl; 2011 Sep; 26(3):255-75. PubMed ID: 20511388
[TBL] [Abstract][Full Text] [Related]
31. Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis.
Lian F; Wang Y; Xiao Y; Wu X; Xu H; Liang L; Yang X
Mol Med Rep; 2015 Oct; 12(4):5821-7. PubMed ID: 26238153
[TBL] [Abstract][Full Text] [Related]
32. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
[TBL] [Abstract][Full Text] [Related]
33. Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration.
Chen S; Tam YY; Lin PJ; Leung AK; Tam YK; Cullis PR
J Control Release; 2014 Dec; 196():106-12. PubMed ID: 25285610
[TBL] [Abstract][Full Text] [Related]
34. TAT-apoptosis repressor with caspase recruitment domain protein transduction rescues mice from fulminant liver failure.
An J; Harms C; Lättig-Tünnemann G; Sellge G; Mandić AD; Malato Y; Heuser A; Endres M; Trautwein C; Donath S
Hepatology; 2012 Aug; 56(2):715-26. PubMed ID: 22392694
[TBL] [Abstract][Full Text] [Related]
35. Suppressor of cytokine signaling 1 protects mice against concanavalin A-induced hepatitis by inhibiting apoptosis.
Torisu T; Nakaya M; Watanabe S; Hashimoto M; Yoshida H; Chinen T; Yoshida R; Okamoto F; Hanada T; Torisu K; Takaesu G; Kobayashi T; Yasukawa H; Yoshimura A
Hepatology; 2008 May; 47(5):1644-54. PubMed ID: 18393318
[TBL] [Abstract][Full Text] [Related]
36. Effect of gal/GalNAc regioisomerism in galactosylated liposomes on asialoglycoprotein receptor-mediated hepatocyte-selective targeting
Nie H; Qiu B; Yang QX; Zhao Y; Liu XM; Zhang YT; Liao FL; Zhang SY
J Liposome Res; 2021 Mar; 31(1):79-89. PubMed ID: 31691619
[TBL] [Abstract][Full Text] [Related]
37. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.
Gehrke N; Hövelmeyer N; Waisman A; Straub BK; Weinmann-Menke J; Wörns MA; Galle PR; Schattenberg JM
J Hepatol; 2018 May; 68(5):986-995. PubMed ID: 29366909
[TBL] [Abstract][Full Text] [Related]
38. Macrophage-targeting and reactive oxygen species (ROS)-responsive nanopolyplexes mediate anti-inflammatory siRNA delivery against acute liver failure (ALF).
Zhang W; Zhou Y; Li X; Xu X; Chen Y; Zhu R; Yin L
Biomater Sci; 2018 Jun; 6(7):1986-1993. PubMed ID: 29855002
[TBL] [Abstract][Full Text] [Related]
39. Hepatocyte-Derived Igκ Exerts a Protective Effect against ConA-Induced Acute Liver Injury.
Yin S; Shi Q; Shao W; Zhang C; Zhang Y; Qiu X; Huang J
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33317072
[TBL] [Abstract][Full Text] [Related]
40. Amphiregulin alleviated concanavalin A-induced acute liver injury
Wu Q; Chen J; Hu X; Zhu Y; Xie S; Wu C; Pei Z; Xiong S; Peng Y
Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):473-483. PubMed ID: 32806961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
